Neutropenia in patients with inflammatory arthritis treated with sulphasalazine.
This report describes two patients who developed severe neutropenia one month after starting sulphasalazine (SASP) as treatment for their inflammatory joint disease. Both recovered on stopping the drug. Six further cases (out of a series of 180 patients with inflammatory forms of arthritis receiving...
Guardat en:
| Publicat a: | Ann Rheum Dis |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMJ Publishing Group
1986
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1001983/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2876683/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.45.9.761 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
